{
  "pmcid": "12146207",
  "sha256": "6a14bb052543706e4a33be8710fab4398fe0cf7b7506ec2e67c25ffb6d00a16a",
  "timestamp_utc": "2025-11-09T23:28:16.867854+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.758022430762189,
    "reading_ease": 30.520160219729945,
    "word_count": 257
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of TREO Stent-Graft for Relining AFX in Type 3b Endoleak"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised to receive either the TREO stent-graft or standard relining procedures."
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at a single surgical center, this randomised controlled trial included patients with type 3b endoleak post-AFX implantation."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either the TREO stent-graft or standard relining procedures."
      },
      "Objective": {
        "score": 1,
        "evidence": "To evaluate the effectiveness of the TREO stent-graft in resolving type 3b endoleaks."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the resolution of the endoleak, assessed by contrast-enhanced CT on postoperative day 5."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not feasible due to the intervention's nature."
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "The TREO stent-graft successfully resolved the endoleak with no adverse events reported."
      },
      "Harms": {
        "score": 1,
        "evidence": "The TREO stent-graft successfully resolved the endoleak with no adverse events reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not applicable."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: No funding was reported for this trial."
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}